Evaluating the Bexa Breast Examination for Breast Cancer Detection
This study is evaluating a new way to detect breast masses, including cancer, called the Bexa Breast Exam (BBE). The BBE uses a device called Bexa, which maps the breast tissue's elasticity to find any lumps, combined with a focused ultrasound to further categorize them. Researchers want to see how well the BBE works compared to standard mammograms in finding breast masses. You may be able to join if you are a woman between 30 and 75 years old who is coming in for a screening mammogram and does not have a history of breast cancer. The main goal is to see how accurately the Bexa Breast Exam can detect masses during the procedure.
- Study design
- This is an interventional study planning to enroll 500 women. It compares the Bexa Breast Exam to standard digital breast tomosynthesis.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, Bexa Sensitivity of Mass Detection, is measured during the procedure, so long-term follow-up is not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Evaluation of the Bexa Breast Examination
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- John Cole, DO · PRINCIPAL_INVESTIGATOR · Hendrick Health
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Bexa Sensitivity of Mass DetectionDuring procedure
Bexa sensitivity of mass detection as compared to digital tomosynthesis mammography